| 5401 |
Apheresis |
Allogeneic |
Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Poland |
46 |
| 5402 |
Apheresis |
Allogeneic |
Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Poland |
62 |
| 5403 |
Apheresis |
Allogeneic |
Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Poland |
47 |
| 5404 |
Apheresis |
Allogeneic |
Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Poland |
33 |
| 5405 |
Apheresis |
Allogeneic |
Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Poland |
45 |
| 5406 |
Apheresis |
Allogeneic |
Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Poland |
43 |
| 5407 |
Apheresis |
Allogeneic |
Myelofibrosis With Myeloid Metaplasia |
Hematology |
2019 |
Standard Therapy |
Poland |
66 |
| 5408 |
Apheresis |
Allogeneic |
Myelofibrosis With Myeloid Metaplasia |
Hematology |
2019 |
Standard Therapy |
Poland |
69 |
| 5409 |
Apheresis |
Allogeneic |
Myelofibrosis With Myeloid Metaplasia |
Hematology |
2019 |
Standard Therapy |
Poland |
63 |
| 5410 |
Apheresis |
Allogeneic |
Myelofibrosis With Myeloid Metaplasia |
Hematology |
2019 |
Standard Therapy |
Poland |
61 |
| 5411 |
Apheresis |
Allogeneic |
Myelofibrosis With Myeloid Metaplasia |
Hematology |
2019 |
Standard Therapy |
Poland |
61 |
| 5412 |
Apheresis |
Allogeneic |
Myeloma Multiplex |
Hematology |
2019 |
Standard Therapy |
Poland |
45 |
| 5413 |
Apheresis |
Allogeneic |
Myeloma Multiplex |
Hematology |
2019 |
Standard Therapy |
Poland |
62 |
| 5414 |
Apheresis |
Autologous |
Myeloma; Amyloidosis |
Hematology |
2019 |
Standard Therapy |
Germany |
47 |
| 5415 |
Apheresis |
Autologous |
Natural Killer / T-Cell-Non-Hodgkin-Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
32 |
| 5416 |
Apheresis |
Allogeneic |
No Data |
Hematology |
2019 |
Standard Therapy |
Poland |
43 |
| 5417 |
Apheresis |
Allogeneic |
No Data |
Hematology |
2019 |
Standard Therapy |
Poland |
20 |
| 5418 |
Apheresis |
Allogeneic |
No Data |
Hematology |
2019 |
Standard Therapy |
Poland |
58 |
| 5419 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
68 |
| 5420 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
28 |
| 5421 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
58 |
| 5422 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
67 |
| 5423 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
51 |
| 5424 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
65 |
| 5425 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
42 |
| 5426 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
55 |
| 5427 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
56 |
| 5428 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
59 |
| 5429 |
Apheresis |
Autologous |
Non-Hodgkin-Lymphoma-Relapse |
Hematology |
2019 |
Standard Therapy |
Germany |
63 |
| 5430 |
Apheresis |
Autologous |
Non-Hodgkin-Lymphoma-Relapse |
Hematology |
2019 |
Standard Therapy |
Germany |
69 |
| 5431 |
Apheresis |
Allogeneic |
Osteomyelofibrosis – Other |
Hematology |
2019 |
Standard Therapy |
Poland |
63 |
| 5432 |
Apheresis |
Allogeneic |
Other Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Poland |
70 |
| 5433 |
Apheresis |
Allogeneic |
Other Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Poland |
61 |
| 5434 |
Apheresis |
Allogeneic |
Other Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Poland |
50 |
| 5435 |
Apheresis |
Allogeneic |
Paroxysmal Nocturnal Hemoglobinuria (Pnh) |
Hematology |
2019 |
Standard Therapy |
Poland |
24 |
| 5436 |
Apheresis |
Allogeneic |
Plasma Cell Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
35 |
| 5437 |
Apheresis |
Allogeneic |
Polycythemia Vera-Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Germany |
58 |
| 5438 |
Apheresis |
Allogeneic |
Post–Polycythemia Vera Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Germany |
70 |
| 5439 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
65 |
| 5440 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
63 |
| 5441 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
69 |
| 5442 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
64 |
| 5443 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
56 |
| 5444 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
57 |
| 5445 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
63 |
| 5446 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
67 |
| 5447 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
78 |
| 5448 |
Apheresis |
Allogeneic |
Primary Immunodeficiency |
Hematology |
2019 |
Standard Therapy |
Poland |
21 |
| 5449 |
Apheresis |
Allogeneic |
Primary Immunodeficiency |
Hematology |
2019 |
Standard Therapy |
Poland |
19 |
| 5450 |
Apheresis |
Allogeneic |
Primary Mediastinal |
Hematology |
2019 |
Standard Therapy |
Poland |
33 |
| 5451 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Poland |
46 |
| 5452 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Poland |
45 |
| 5453 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2019 |
Standard Therapy |
Germany |
55 |
| 5454 |
Apheresis |
Allogeneic |
Relapsed Peripheral T Cell Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
65 |
| 5455 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
59 |
| 5456 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Germany |
64 |
| 5457 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Germany |
60 |
| 5458 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia At Myeloproliferative Neoplasms |
Hematology |
2019 |
Standard Therapy |
Germany |
56 |
| 5459 |
Apheresis |
Autologous |
Secondary Primary Central Nervous System Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
66 |
| 5460 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2019 |
Standard Therapy |
Poland |
12 |
| 5461 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2019 |
Standard Therapy |
Poland |
11 |
| 5462 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2019 |
Standard Therapy |
Poland |
55 |
| 5463 |
Apheresis |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2019 |
Standard Therapy |
Poland |
1 |
| 5464 |
Apheresis |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
44 |
| 5465 |
Apheresis |
Autologous |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
55 |
| 5466 |
Apheresis |
Autologous |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
59 |
| 5467 |
Apheresis |
Allogeneic |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
67 |
| 5468 |
Apheresis |
Allogeneic |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
45 |
| 5469 |
Apheresis |
Autologous |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
72 |
| 5470 |
Apheresis |
Autologous |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
61 |
| 5471 |
Apheresis |
Autologous |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
61 |
| 5472 |
Apheresis |
Autologous |
Testicular Cancer Relapse |
Hematology |
2019 |
Standard Therapy |
Germany |
29 |
| 5473 |
Apheresis |
Allogeneic |
Thalassemia Major |
Hematology |
2019 |
Standard Therapy |
Poland |
20 |
| 5474 |
Apheresis |
Allogeneic |
Wiskott-Aldrich Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
1 |
| 5475 |
Apheresis |
Allogeneic |
Β – Thalassemia |
Hematology |
2019 |
Standard Therapy |
Poland |
13 |
| 5476 |
Adipose Tissue |
Autologous |
Chondromalacia |
Orthopedy |
2019 |
Experimental Therapy |
Poland |
48,8 |
| 5477 |
Adipose Tissue |
Autologous |
Chondromalacia |
Orthopedy |
2019 |
Experimental Therapy |
Poland |
38,6 |
| 5478 |
Adipose Tissue |
Autologous |
Coxarthrosis |
Orthopedy |
2019 |
Experimental Therapy |
Poland |
34 |
| 5479 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5480 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5481 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5482 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5483 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5484 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5485 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5486 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5487 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5488 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5489 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5490 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5491 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5492 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5493 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5494 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5495 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5496 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5497 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5498 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5499 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |
| 5500 |
Adipose Tissue |
Autologous |
Cutis Laxa |
Dermatology |
2019 |
Clinical Trial |
Poland |
no data |